Soizic Dutoit Selected Research

Soizic Dutoit Research Topics

Disease

10	Neoplasms (Cancer) 01/2020 - 09/2008
9	Ovarian Neoplasms (Ovarian Cancer) 10/2017 - 02/2005
6	Carcinoma (Carcinomatosis) 10/2017 - 02/2005
3	Testicular Neoplasms (Testicular Cancer) 02/2011 - 09/2008
2	Embryonal Carcinoma 02/2011 - 03/2009
2	Adenocarcinoma 01/2008 - 04/2005
1	Mesothelioma 01/2020
1	Malignant Mesothelioma 01/2020
1	Melanoma (Melanoma, Malignant) 01/2018
1	Peritoneal Neoplasms 10/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016
1	Hypoxia (Hypoxemia) 09/2012
1	Necrosis 02/2011
1	Teratoma (Teratoid Tumor) 02/2011
1	Ovarian Epithelial Carcinoma 02/2005
1	Neoplasm Metastasis (Metastasis) 02/2005

Drug/Important Bio-Agent (IBA)

6	IntegrinsIBA 02/2011 - 02/2005
4	Cisplatin (Platino)FDA LinkGeneric 01/2013 - 03/2009
3	VitronectinIBA 04/2010 - 01/2008
3	Integrin alphaVIBA 04/2010 - 01/2008
2	TOR Serine-Threonine KinasesIBA 12/2015 - 01/2013
2	ABT-737IBA 03/2015 - 04/2013
1	Interferon Type IIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	HLA-DPw4 antigenIBA 01/2018
1	AntigensIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 10/2017
1	atelocollagenIBA 10/2017
1	LuciferasesIBA 10/2017
1	DNA-Activated Protein KinaseIBA 01/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2015
1	Caspase 3 (Caspase-3)IBA 03/2015
1	Carboplatin (JM8)FDA LinkGeneric 03/2015
1	Platinum Compounds (Compounds, Platinum)IBA 04/2013
1	Apoptosis Regulatory ProteinsIBA 04/2013
1	Excipients (Suspending Agents)IBA 01/2013
1	Carrier Proteins (Binding Protein)IBA 01/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2012
1	Etoposide (VP 16)FDA LinkGeneric 02/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2011
1	hydrazinonicotinic acidIBA 02/2011
1	cyclo(arginylglycyl)IBA 02/2011
1	Biological ProductsIBA 04/2010
1	ethyl 2- amino- 6- bromo- 4- (1- cyano- 2- ethoxy- 2- oxoethyl)- 4H- chromene- 3- carboxylateIBA 11/2009
1	Antineoplastic Agents (Antineoplastics)IBA 11/2009
1	Proteins (Proteins, Gene)FDA Link 11/2009
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 09/2008
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	Cyclin AIBA 09/2008
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2008
1	Blocking AntibodiesIBA 01/2008
1	Cyclic PeptidesIBA 01/2008
1	Peptide Hydrolases (Proteases)FDA Link 04/2005
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 04/2005
1	Integrin beta ChainsIBA 02/2005
1	PlatinumIBA 02/2005
1	ParaffinIBA 02/2005
1	integrin beta6IBA 02/2005

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 04/2013 - 03/2009
3	Therapeutics 12/2015 - 01/2013
2	Immunotherapy 01/2020 - 01/2018
1	Withholding Treatment 01/2013
1	Aftercare (After-Treatment) 02/2011